Translate Bio
Translate Bio is a Massachusetts-based biotechnology company that researches and develops mRNA therapeutics for the treatment of genetic diseases.
Business Model:
Revenue: $225M
Employees: 51-200
Industries / Tags:
Detailed Translate Bio Information
Translate Bio was acquired by
Sanofi.
The acquisition happend on 2021-08-03.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 29 Hartwell Ave.
City: Lexington
State: MA
Zip: 02421
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$47M
Raised Total:$228M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Translate Bio is a Massachusetts-based biotechnology company that researches and develops mRNA therapeutics for the treatment of genetic diseases.
Contact Phone:
+16179457361
Contact Email:
Translate Bio went public on 6/27/2018 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/27/2018
IPO Valuation:
$582M
Ticker Symbol:
TBIO
IPO Price:
$13/share
Amount Raised:
$122M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
